Transanal total mesorectal excision: Myths and reality.

Buchs NC; Penna M; Bloemendaal AL; Hompes R

doi:10.5306/wjco.v7.i5.337

Back

Journal article

Transanal total mesorectal excision: Myths and reality.

Buchs NC Nicolas C Buchs, Division of Visceral Surgery, Department of Surgery, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Penna M Nicolas C Buchs, Division of Visceral Surgery, Department of Surgery, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Bloemendaal AL Nicolas C Buchs, Division of Visceral Surgery, Department of Surgery, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Hompes R Nicolas C Buchs, Division of Visceral Surgery, Department of Surgery, University Hospitals of Geneva, 1211 Geneva, Switzerland.

2016-10-26

Published in:

World journal of clinical oncology. - 2016

Transanal total mesorectal excision

English Transanal total mesorectal excision (TaTME) is a new and promising approach for the treatment of rectal cancer. Whilst the experience is still limited, there are growing evidences that this approach might overcome the limits of standard low anterior resection. TaTME might help to decrease the conversion rate especially in difficult patients, and to improve the pathological results, while preserving the urogenital function. Evaluation of data from large registries and randomized studies should help to draw firmer conclusions. Beyond these technical considerations, the next challenge seems to be clearly the safe introduction of this approach, motivating the development of dedicated courses.

Language